Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells

Marion Vanneste 1 Vincent Hanoux 1 Mohammed Bouakka Pierre-Jacques Bonnamy 1
1 OeReCa - Œstrogènes, reproduction, cancer
Abstract : In breast carcinoma cells, high levels of hyaluronan (HA) and its CD44 receptor are frequently associated with alteration in estrogen signaling. We demonstrate that stable hyaluronate synthase 2 (HAS2) overexpression in estrogen receptor α (ERα) -positive MCF7 cells oppositely altered estrogen dependence of cell growth and its sensitivity towards antiestrogens. Albeit without effect on ERα expression and estradiol binding properties, HAS2 overexpression increased ERα Ser118 phosphorylation as well as transcriptional activity of estrogen in an ERE-luciferase reporter gene assay. However, HAS2 overexpression induced partial silencing of E2 driven-genes without affecting the magnitude of regulation by estradiol. This effect was associated with half-reduction in the activity of nuclear histone deacetylases (HDACs) through a post-translational mechanism likely consecutive to the enhanced expression of the histone acetyl-transferase EP300. In conclusion, increase in HA/CD44 interactions may contribute, through an HDAC inhibitor-like and ER-independent mechanism, to the silencing of estrogen-driven genes in breast carcinoma.
Keywords : Breast cancer Estrogen signaling Histone deacetylases Hyaluronan Hyaluronate synthase 2
Type de document :
Article dans une revue
Liste complète des métadonnées
https://hal-normandie-univ.archives-ouvertes.fr/hal-02154936
Contributeur : Hélène Bouraïma-Lelong <>
Soumis le : jeudi 13 juin 2019 - 11:10:56
Dernière modification le : vendredi 14 juin 2019 - 02:06:21

Identifiants

Collections

COMUE-NORMANDIE | OERECA | UNICAEN

Citation

Marion Vanneste, Vincent Hanoux, Mohammed Bouakka, Pierre-Jacques Bonnamy. Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells. Molecular and Cellular Endocrinology, Elsevier, 2017, 444, pp.48-58. ⟨10.1016/j.mce.2017.01.046⟩. ⟨hal-02154936⟩

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

15